These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 17689296)

  • 1. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study.
    Welzel TM; Graubard BI; El-Serag HB; Shaib YH; Hsing AW; Davila JA; McGlynn KA
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1221-8. PubMed ID: 17689296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare.
    Petrick JL; Yang B; Altekruse SF; Van Dyke AL; Koshiol J; Graubard BI; McGlynn KA
    PLoS One; 2017; 12(10):e0186643. PubMed ID: 29049401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China.
    Tao LY; He XD; Qu Q; Cai L; Liu W; Zhou L; Zhang SM
    Liver Int; 2010 Feb; 30(2):215-21. PubMed ID: 19840244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study.
    Shaib YH; El-Serag HB; Nooka AK; Thomas M; Brown TD; Patt YZ; Hassan MM
    Am J Gastroenterol; 2007 May; 102(5):1016-21. PubMed ID: 17324130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of cholangiocarcinoma.
    Shaib Y; El-Serag HB
    Semin Liver Dis; 2004 May; 24(2):115-25. PubMed ID: 15192785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic variation of intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and hepatocellular carcinoma in the United States.
    Altekruse SF; Petrick JL; Rolin AI; Cuccinelli JE; Zou Z; Tatalovich Z; McGlynn KA
    PLoS One; 2015; 10(3):e0120574. PubMed ID: 25837669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.
    Welzel TM; McGlynn KA; Hsing AW; O'Brien TR; Pfeiffer RM
    J Natl Cancer Inst; 2006 Jun; 98(12):873-5. PubMed ID: 16788161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Incidence and Factors Affecting Survival of Patients With Cholangiocarcinoma in the United States.
    Mukkamalla SKR; Naseri HM; Kim BM; Katz SC; Armenio VA
    J Natl Compr Canc Netw; 2018 Apr; 16(4):370-376. PubMed ID: 29632056
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
    Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
    Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secular trends in the incidence of cholangiocarcinoma in the USA and the impact of misclassification.
    Tyson GL; Ilyas JA; Duan Z; Green LK; Younes M; El-Serag HB; Davila JA
    Dig Dis Sci; 2014 Dec; 59(12):3103-10. PubMed ID: 25204668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.
    Bertuccio P; Malvezzi M; Carioli G; Hashim D; Boffetta P; El-Serag HB; La Vecchia C; Negri E
    J Hepatol; 2019 Jul; 71(1):104-114. PubMed ID: 30910538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans.
    El-Serag HB; Engels EA; Landgren O; Chiao E; Henderson L; Amaratunge HC; Giordano TP
    Hepatology; 2009 Jan; 49(1):116-23. PubMed ID: 19085911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological survey of biomarkers of hepatitis virus in patients with extrahepatic cholangiocarcinomas.
    Qu Z; Cui N; Qin M; Wu X
    Asia Pac J Clin Oncol; 2012 Mar; 8(1):83-7. PubMed ID: 22369448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise.
    Saha SK; Zhu AX; Fuchs CS; Brooks GA
    Oncologist; 2016 May; 21(5):594-9. PubMed ID: 27000463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
    Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
    J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
    Shaib YH; El-Serag HB; Davila JA; Morgan R; McGlynn KA
    Gastroenterology; 2005 Mar; 128(3):620-6. PubMed ID: 15765398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C; Jibara G; Ward SC; Fan C; Qin L; Roayaie S; Fiel MI; Schwartz M; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study.
    Welzel TM; Mellemkjaer L; Gloria G; Sakoda LC; Hsing AW; El Ghormli L; Olsen JH; McGlynn KA
    Int J Cancer; 2007 Feb; 120(3):638-41. PubMed ID: 17109384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
    Florio AA; Ferlay J; Znaor A; Ruggieri D; Alvarez CS; Laversanne M; Bray F; McGlynn KA; Petrick JL
    Cancer; 2020 Jun; 126(11):2666-2678. PubMed ID: 32129902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent of Primary Sclerosing Cholangitis and Cirrhosis, Early Adulthood Obesity Is Associated with Cholangiocarcinoma.
    Hatia RI; Eluri M; Hawk ET; Shalaby A; Karatas E; Shalaby A; Abdelhakeem A; Abdel-Wahab R; Chang P; Rashid A; Jalal PK; Amos CI; Han Y; Armaghany T; Shroff RT; Li D; Javle M; Hassan MM
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1338-1347. PubMed ID: 37540502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.